Target intelligence / Profile preview

Aortic valve (null)

Target
null
Molecular classification
Other
01

Overview

The aortic valve is a trileaflet, semilunar valve located between the left ventricle of the heart and the ascending aorta. It is composed of three thin, flexible leaflets (cusps) made mostly of collagen surrounded by an endothelial lining, anchored by the aortic annulus and supported by a fibrous skeleton. The aortic valve ensures unidirectional blood flow during systole (ventricular contraction) and prevents retrograde flow of blood into the left ventricle during diastole. The valve operates under high pressure and is subject to age- and disease-related degenerative changes, as well as congenital malformations such as bicuspid aortic valve. Dysfunction of the native aortic valve is a major cause of cardiovascular morbidity and may necessitate surgical or interventional replacement with prosthetic or bioprosthetic valves[1][5][3]. Note: - "Native aortic valve" is not a molecular target recognized in drug development (such as a receptor, enzyme, or signaling protein). It is a gross anatomical structure with critical physiological and pathological roles, but not a target for drug binding or modulation at the molecular level[1][5][3]. - In clinical and research contexts, interventions on the aortic valve are primarily surgical or device-based, not pharmacological at the level of direct molecular modification.

Other names
Native aortic valvenative semilunar aortic valve
02

Mechanism of action

null

03

Biological functions

Maintains unidirectional blood flow from the left ventricle to the aortaprevents backflow into the left ventricle
04

Disease associations

Cardiovascular disease (including aortic stenosis, aortic regurgitation, infective endocarditis, congenital malformations like bicuspid aortic valve)
05

Safety considerations

Degeneration (calcification, fibrosis, sclerosis)risk of infective endocarditisvalvular dysfunction (stenosis, regurgitation)hemolysis post-replacement

Beyond the preview

Go deeper on Aortic valve (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aortic valve (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call